4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-19-000013
Director sold 18,889 shares at $18.90 ($357,002)
- Director acquired 18,889 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HIPP RAYMOND R · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-26 | Exercise or conversion : show line 1 in the form | +10,000 | $4.78 | $47,800 | 297,580 | D |
| 2019-02-26 | Exercise or conversion : show line 2 in the form | +5,556 | $9.11 | $50,615 | 303,136 | D |
| 2019-02-26 | Exercise or conversion : show line 3 in the form | +3,333 | $7.27 | $24,231 | 306,469 | D |
| 2019-02-26 | Sale : show line 4 in the form | −18,889 | $18.90 | $357,002 | 287,580 | D |
| Open-market sales · 18,889 sh · avg $18.90 · $357,002 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-02-26 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −10,000 | $4.78 | 2020-05-06 | 10,000 | 0 | D |
| 2019-02-26 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −5,556 | $9.11 | 2021-07-28 | 5,556 | 2,777 | D |
| 2019-02-26 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −3,333 | $7.27 | 2022-05-25 | 3,333 | 6,667 | D |
Loading xslF345X03/wf-form4_155139102644751.xml…